This week, five health care provider stocks are improving their overall rating on Portfolio Grader. Each of these rates an “A” (“strong buy”) or “B” overall (“buy”).
Cross Country Healthcare, Inc. (CCRN) is bettering its rating of C (“hold”) from last week to a B (“buy”) this week. Cross Country Healthcare provides healthcare staffing and outsourcing services to the healthcare market. In Portfolio Grader’s specific subcategories of Earnings Momentum, Earnings Surprise and Sales Growth, CCRN also gets A’s. For more information, get Portfolio Grader’s complete analysis of CCRN stock.
Triple-S Management Corporation Class B (GTS) earns a C this week, jumping up from last week’s grade of A. Triple-S Management is an independent licensee of the Blue Cross Blue Shield Association. For more information, get Portfolio Grader’s complete analysis of GTS stock.
Fresenius Medical Care AG & Co. KGaA Sponsored ADR (FMS) is seeing ratings go up from a C last week to a B this week. Fresenius Medical Care offers kidney dialysis services and manufactures and distributes equipment and products used in the treatment of dialysis patients. For more information, get Portfolio Grader’s complete analysis of FMS stock.
This week, Bio-Reference Laboratories, Inc. (BRLI) is showing good progress as the company’s rating jumps from a B (“buy”) last week to an A (“strong buy”). Bio-Reference provides laboratory testing services, primarily to customers in the greater New York metropolitan area. For more information, get Portfolio Grader’s complete analysis of BRLI stock.
DaVita HealthCare Partners Inc. (DVA) gets a higher grade this week, advancing from a C last week to a B. DaVita operates kidney dialysis centers in the United States. For more information, get Portfolio Grader’s complete analysis of DVA stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
